A sestamibi (MIBI) scan was suspicious of a right-sided parathyroid adenoma, while genetic testing confirmed heterozygosity for a pathogenic RET variant, conferring risk of developing other MEN2-related tumours. The gene discussed is RET; the disease is neoplasm.